| Nov 14 |
BiomX GAAP EPS of -$0.31 beats by $0.19
|
| Nov 14 |
BiomX Inc. (PHGE) Q3 2024 Earnings Call Transcript
|
| Nov 14 |
BiomX Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 14 |
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates
|
| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 12 |
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024
|
| Oct 16 |
BiomX announces mandatory unit separation
|
| Oct 15 |
BiomX announces a mandatory unit separation
|
| Oct 15 |
BiomX Announces a Mandatory Unit Separation
|
| Sep 18 |
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference
|
